AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ONCOSIL MEDICAL LTD

1.165

+0.0050.43%

Volume:124.94K

Turnover:144.91K

Market Cap:35.99M

PE:-1.24

High:1.195

Open:1.165

Low:1.135

Close:1.160

52wk High:2.090

52wk Low:0.370

Shares:30.89M

Float Shares:16.80M

Volume Ratio:0.66

T/O Rate:0.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.940

EPS(LYR):-1.382

ROE:-208.41%

ROA:-87.11%

PB:9.38

PE(LYR):-0.84

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+2.85%

Capital Flow

Inflow:

Outflow:

News

Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma

THOMSON REUTERS

Oncosil Medical - FY26 Unit Sales up 53%, Revenue up 44% Versus FY25

THOMSON REUTERS

Oncosil Medical Ltd-new Independent Study Confirms Oncosil Dose Flexibility

THOMSON REUTERS

Oncosil Medical Ltd - Oncosil Medical Receives Saudi FDA Approval

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/OSL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":1.165,"timestamp":1787638320000,"preClose":1.16,"halted":0,"volume":124944,"delay":0,"changeRate":0.004310344827586307,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":16797755,"shares":30888898,"eps":-0.94,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"08-25 16:12:00 AEST","open":1.165,"high":1.195,"low":1.135,"amount":144907,"amplitude":0.051724,"askPrice":1.2,"askSize":6500,"bidPrice":1.15,"bidSize":11361,"shortable":3,"etf":0,"ttmEps":-0.94,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.16,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.662148,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSL.AU","preClose":1.16,"auctionPrice":1.165,"auctionVolume":5592,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638194230}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":16797755,"roa":"-87.11%","roe":"-208.41%","lyrEps":-1.381715,"volumeRatio":0.662148,"shares":30888898,"dividePrice":0,"high":1.195,"amplitude":0.051724,"preClose":1.16,"low":1.135,"week52Low":0.37,"pbRate":"9.38","psRate":"9.66","week52High":2.09,"institutionHeld":0,"latestPrice":1.165,"committee":0.272157,"eps":-0.94,"divideRate":0,"volume":124944,"delay":0,"ttmEps":-0.94,"open":1.165,"prevYearClose":0.97,"prevWeekClose":1.15,"prevMonthClose":1.16,"prevQuarterClose":0.71,"fiveDayClose":1.15,"twentyDayClose":1.03,"sixtyDayClose":0.485,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-03","symbol":"OSL.AU","defaultRemindTime":1748908800000,"type":"split","dateTimestamp":1748872800000,"forFactor":400,"toFactor":1,"ratio":400},{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660820103","title":"Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660820103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660820103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:36","pubTimestamp":1786919772,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nFWN44C06B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655103238","title":"Oncosil Medical - FY26 Unit Sales up 53%, Revenue up 44% Versus FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2655103238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655103238?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:43","pubTimestamp":1785365003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V1OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717847","title":"Oncosil Medical Ltd-new Independent Study Confirms Oncosil Dose Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653717847?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:41","pubTimestamp":1784846460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUE7KXW7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652776250","title":"Oncosil Medical Ltd - Oncosil Medical Receives Saudi FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2652776250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652776250?lang=en_us&edition=fundamental","pubTime":"2026-07-20 06:31","pubTimestamp":1784500317,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nFWN43K034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","OSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OSL.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}